Business
Clinuvel (ASX:CUV) share price falls despite positive update
The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price is tumbling in early morning trade. This comes despite releasing an update to the market. At the time of writing, the biopharmaceutical company’s shares are swapping hands for $27.99, down 2.3%.
What did Clinuvel announce?
The Clinuvel share price is being weighed down by investors despite the company’s positive announcement.
According to this morning’s release, Clinuvel advised that it has now expanded its DNA repair program. The clinical trials will now evaluate afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure. Patients suffering from rare…
-
General17 hours agoSearch underway for missing boat off South Australia’s Cape Jaffa
-
Noosa News18 hours agoQueensland coroner investigates ‘extremely unusual’ deaths of premature twin boys
-
General20 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News19 hours agoChristmas tragedy: NSW woman dies after alleged deliberate hit-and-run on Sunshine Coast